Buy Eiger BioPharmaceuticals Stock | EIGR Stock Price & Latest News | Public
EIGR

Eiger BioPharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap

    About EIGR

    Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.2
    -0.08
    -0.35
    -0.62
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    $0.20

    Actual EPS
    Q4 2020

    Stats

    Market Cap$299,29M
    Volume14,12k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$15.82
    1 Year Low$4.55
    Open$9.25
    High$9.25
    Low$8.75

    Buy any stock with any amount of money.

    Download the App
    Download the app